Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Author:

Gallwitz, Baptist

Tübinger Autor(en):

Published in:

Frontiers in Endocrinology (2022), Bd. 13, Article 1004044

Verlagsangabe:

Frontiers Media Sa

Language:

English

Full text:

ISSN:

1664-2392

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)